Close
Practical Applications of New Agents in Oncology
Thursday, February 12, 2026
to
Friday, February 13, 2026
Register today
-
About
About This Event
Now in its 28th year, Practical Applications of New Agents in Oncology (PANAO) returns this February, bringing together leading voices in oncology and hemotology to explore what’s next in cancer care. The two-day conference will spotlight recently approved and investigational anticancer agents, emerging data from new clinical studies and evolving treatment strategies.
This year’s program features a distinguished lineup, including keynote speaker Daniel Von Hoff, MD, of TGen, presenting Unexplored Frailties of Cancer.
PANAO offers accredited continuing medical education (CME), pharmacy education (CPE) and nursing education (CNE) for healthcare professionals specializing in oncology and hematology. Complimentary registration is also available for UT Health San Antonio staff, trainees, students and select attendees, including nurses, residents, fellows and patient advocates.
-
Agenda
Agenda
Thursday, Feb. 12, 2026 (Day 1) 7–7:50 a.m. Registration and Breakfast 7:50–8 a.m. Opening Remarks: Daruka Mahadevan, MD, PhD, UT Health San Antonio, Mays Cancer Center 8–8:45 a.m. Special Session: Inaugural Dan Von Hoff Lectureship | Moderator: Daruka Mahadevan, MD, PhD, UT Health San Antonio, Mays Cancer Center 8–8:40 a.m. Unexplored Frailties of Cancer | Daniel Von Hoff, MD, TGEN, Arizona 8:40–8:45 a.m. Questions & Answers 8:45–8:55 a.m. Break 8:55–10:35 a.m. Session 1: Therapeutic Advances in GI Cancers | Moderator: Georgios Fotopoulos, MD, UT Health San Antonio, Mays Cancer Center 8:55–9:25 a.m. Advances in Liver Cancer | Sukeshi Arora, MD, UT Health San Antonio 9:25–9:55 a.m. CAR-T Therapy in Liver Cancer | Anuradha Krishnamurthy, MD, Roswell Park 9:55–10:25 a.m. Advances in Colorectal Cancer | Sreenivasa Chandana, MD, PhD, START, Grand Rapids, MI 10:25–10:35 a.m. Questions & Answers 10:35–10:55 a.m. Break 10:55–12:30 p.m. Session 2: Novel Agents in Drug Development | Moderator: John Sarantopoulos, MD, UT Health San Antonio 10:55–11:25 a.m. Current Advances in Antibody Drug Conjugates | Daruka Mahadevan, MD, PhD, UT Health San Antonio 11:25–11:55 a.m. Recent Advances in Bispecific Antibodies in Lung Cancer | Kai He, MD, PhD, Ohio State University 11:55–12:25 p.m. Advances in Protein Degradation | Jin Wang, PhD, Baylor College of Medicine 12:25–12:30 p.m. Questions & Answers 12:30–1:40 p.m. Lunch, Networking and Exhibition 1:40–3:30 p.m. Session 3: AI in Therapeutic Target Identification and New Drug Discovery | Moderator: Daruka Mahadevan, MD, UT Health San Antonio 1:40–2:10 p.m. Rethinking Data Access and Analytics for Novel Therapeutic Targets | Ritu Pandey, PhD, University of Arizona 2:10–2:50 p.m. Molecular Case Report | Jay Parekh, MD, UT Health San Antonio AI in Molecular Profile | Jeannie Kowalski, PhD, UT Austin 2:50–3:20 p.m. Accelerating Drug Discovery with AI | Dmytro Kovalskyy, PhD, UT Health San Antonio 3:20–3:30 p.m. Questions & Answers 3:30–3:50 p.m. Break 3:50–5:30 p.m. Session 4: Immune and Cellular Therapies for GU Cancers | Moderator: John Sarantopoulos, MD, UT Health San Antonio 3:50–4:20 p.m. Implications of I RAE and Discontinuation of Immune Checkpoint Inhibitor Therapy in RCC Patients | Saby George, MD, Roswell Park 4:20–4:50 p.m. Driving Towards a Cure in Genitourinary Cancers with Cellular Therapy | Benjamin Maughan, MD, PharmD, University of Utah 4:50–5:20 p.m. Updates in the Management of AML | Eytan Stein, MD, Memorial Sloan Kettering Cancer Center 5:20–5:30 p.m. Questions & Answers 5:30 p.m. Day 1 Adjournment Friday, Feb. 13, 2026 (Day 2) 7–8 a.m. Registration, Breakfast & Exhibits 8– 9:40 a.m. Session 5. Advances of Drug Development in Hematology | Moderator: Zohra Nooruddin, MD, UT Health San Antonio 8– 8:30 a.m. Lymphoma | Julio Chavez, MD, Mayo Clinic 8:30– 9:00 a.m. MDS | Guillermo Garcia-Manero, MD, MD Anderson 9–9:30 a.m. Benign Hematology | Usha Perepu, MD, UT Health San Antonio 9:30–9:40 a.m. Questions & Answers 9:40–10:10 a.m. Break 10:10 a.m. -11:50 a.m. Session 6. Moderator: TBD 10:10–10:40 a.m. Breast Cancer | Marcela Mazo Canola, MD, UT Health San Antonio 10:40–11:10 a.m. Sarcoma | Catherine Wilbur, MD, Johns Hopkins 11:10–11:40 a.m. KRAS SMI | David Hong, MD, MD Anderson 11:40 a.m. – 11:50 a.m. Questions & Answers 11:50 a.m. –1 p.m. Lunch, Networking and Exhibition 1–1:35 p.m. Session 5: Research Award | Moderator: John Sarantopoulos, MD, UT Health San Antonio 1–1:15 p.m. Overcoming Barriers to Enrollment in Phase 1 Oncology Clinical Trials | Avery Alva, RN, UT Health San Antonio 1:15–1:20 p.m. Questions & Answers 1:20–1:25 p.m. Award Presentation and Closing Remarks | Daruka Mahadevan, MD, PhD and John Sarantopoulos, MD 1:30 p.m. Close of Program -
Date and Time
Date and Time
- Thursday, February 12, 2026, 7:00AM
- to Friday, February 13, 2026, 2:00PM
-
Location
Location
Embassy Suites by Hilton San Antonio Landmark
5615 Landmark Parkway
Book your room through the conference room block and save
San Antonio, TX, 78249
*Free on-site parking is provided for all attendees -
Contact
Contact
For questions about the conference, please send an email to PANAO@uthscsa.edu
-
Exhibitor Details
Exhibitor Details
-
Registration
